Funding declines in pharma as June sees 97% plunge
Total funding reached $7.2 million across 5 rounds, representing a 97.07 per cent decrease from May 2025
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Parexel appoints two FDA luminaries, Dr Lola Fashoyin-Aje, and Dr Tala Fakhouri to its Consulting…
These strategic appointments will bolster the company’s regulatory expertise
EU approves Biocon Biologics’ Denosumab biosimilars
Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor…
Vaccine sales plummet in China, posing a challenge for big pharma: GlobalData
GlobalData attributes this drop to price competition from local manufacturers and China’s ongoing anti-corruption crackdown on the…
Pharmexcil reports robust exports: $ 2,475.70 mn in May 2025, Cumulating to $ 4,961.71 mn for…
According to the reports, a 7.38 per cent expansion was observed compared to May 2024-25
Cadila Pharmaceuticals launches Bilacad Dex Syrup
Bilacad Dex Syrup is a triple-action formula for comprehensive respiratory relief
High costs and limited access threaten progress in HIV treatment despite new drug advances:…
GlobalData’s report reveals that unmet needs, including underfunding of prevention programs, poor mental health integration,…
Nontuberculous mycobacteria market to reach $4.6 billion in 7MM in 2033, forecasts GlobalData
Market expansion driven by novel pipeline drugs and rising diagnosed prevalence, but generic competition may limit uptake of…
Torrent Pharmaceuticals to acquire controlling stake in JB Pharma from KKR for ₹25,689 crore,…
Torrent to first acquire 46.39 per cent stake in JB Pharma and initiate open offer, aiming to integrate operations through merger…
Biopharma innovation meets market headwinds tempering optimism: GlobalData
GlobalData’s report captures a moment for the global biopharmaceutical sector, where the pace of innovation is clashing with a…
Access to diabetes care for children and young people: Pharma companies’ current actions and…
A recently released report from Access to Medicine Foundation highlights that children and young people living in low-and…
Pharma sector sees $6.96 billion in global deal activity in May 2025, led by GSK, Shionogi, and Eli…
M&A and venture capital deals in the global healthcare sector declined from the 12-month average, with three transactions…
India’s pharma startups raise $254.7 million in May 2025: Tracxn
Seed-stage deals dominate as funding surges over fivefold from April, led by PB Healthcare’s $156 million round
India’s pharma funding falls by over 90% YoY in April 2025
Total funding drops to $57.7 million across 14 rounds, with early-stage investments comprising over half the capital deployed
SeQuent–Viyash merger receives stock exchange approvals; NCLT filing underway
The merger will bring together two business verticals—Global Animal Health and an integrated API business
GlobalData forecasts ADC NSCLC market to reach $3.9 bn in 2032
GlobalData’s patient-based forecast highlights that ADCs will see significant sales in the NSCLC space by 2032, led by…
China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024
Significant reforms in clinical development processes and regulatory reviews in China have led to faster drug approvals,…
Cadila Pharmaceuticals launches Empadon (Empagliflozin)
Clinical trials have consistently shown empagliflozin’s efficacy in reducing cardiovascular mortality, heart failure…
Quadria Capital closes oversubscribed $1 bn fund III to advance healthcare across Asia
This latest fundraise is around 60 per cent larger than the firm’s previous $600 million fund raised in 2020
Biocon Biologics, Yoshindo launch Ustekinumab biosimilar in Japan
Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis (PsA)